The prevalence of sarcopenia in patients with chronic pancreatitis : a meta-analysis
AIM: Systematization of data on the prevalence of sarcopenia in patients with chronic pancreatitis (CP).
MATERIALS AND METHODS: MEDLINE/PubMed, EMBASE, Cochrane, the Russian Science Citation Index (RSCI) through June 2020 were searched to identify studies evaluating the prevalence of sarcopenia in CP. Additionally, a search for relevant abstracts was carried out in the electronic databases of the conferences of the European Pancreatic Club (EPC), the International Association of Pancreatology (IAP) and the European Congress of Radiology (ECR). For the final analysis, publications were selected that used validated muscle mass assessment tests with detailed descriptive statistics to enable the resulting data to be included in the meta-analysis.
RESULTS: The final analysis included 7 studies involving 604 patients with CP. The pooled prevalence of sarcopenia in patients with CP was 42.09% (95% confidence interval CI 27.84557.055). There was significant heterogeneity between the results (p0.0001; I2=90.81%). When studies with a total sample of less than 50 patients were excluded from the meta-analysis, the overall prevalence of sarcopenia in patients with CP was 22.24% (95% CI 15.47529.847).
CONCLUSION: The present meta-analysis demonstrated that sarcopenia is a common complication of CP and is observed in about 2 out of 5 patients with this inflammatory disease of the pancreas. Given the high incidence of adverse outcomes associated with sarcopenia, it is necessary to promptly diagnose this pathological condition in patients with CP.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
|---|---|
| Enthalten in: |
Terapevticheskii arkhiv - 92(2020), 12 vom: 15. Dez., Seite 43-47 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Maev, I V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic pancreatitis |
|---|
| Anmerkungen: |
Date Completed 17.03.2021 Date Revised 17.03.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.26442/00403660.2020.12.200430 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322772931 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322772931 | ||
| 003 | DE-627 | ||
| 005 | 20231225182739.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.26442/00403660.2020.12.200430 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1075.xml |
| 035 | |a (DE-627)NLM322772931 | ||
| 035 | |a (NLM)33720572 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Maev, I V |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The prevalence of sarcopenia in patients with chronic pancreatitis |b a meta-analysis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.03.2021 | ||
| 500 | |a Date Revised 17.03.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a AIM: Systematization of data on the prevalence of sarcopenia in patients with chronic pancreatitis (CP) | ||
| 520 | |a MATERIALS AND METHODS: MEDLINE/PubMed, EMBASE, Cochrane, the Russian Science Citation Index (RSCI) through June 2020 were searched to identify studies evaluating the prevalence of sarcopenia in CP. Additionally, a search for relevant abstracts was carried out in the electronic databases of the conferences of the European Pancreatic Club (EPC), the International Association of Pancreatology (IAP) and the European Congress of Radiology (ECR). For the final analysis, publications were selected that used validated muscle mass assessment tests with detailed descriptive statistics to enable the resulting data to be included in the meta-analysis | ||
| 520 | |a RESULTS: The final analysis included 7 studies involving 604 patients with CP. The pooled prevalence of sarcopenia in patients with CP was 42.09% (95% confidence interval CI 27.84557.055). There was significant heterogeneity between the results (p0.0001; I2=90.81%). When studies with a total sample of less than 50 patients were excluded from the meta-analysis, the overall prevalence of sarcopenia in patients with CP was 22.24% (95% CI 15.47529.847) | ||
| 520 | |a CONCLUSION: The present meta-analysis demonstrated that sarcopenia is a common complication of CP and is observed in about 2 out of 5 patients with this inflammatory disease of the pancreas. Given the high incidence of adverse outcomes associated with sarcopenia, it is necessary to promptly diagnose this pathological condition in patients with CP | ||
| 650 | 4 | |a Classical Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a chronic pancreatitis | |
| 650 | 4 | |a enzyme replacement therapy | |
| 650 | 4 | |a muscle mass | |
| 650 | 4 | |a nutritional status | |
| 650 | 4 | |a sarcopenia | |
| 700 | 1 | |a Andreev, D N |e verfasserin |4 aut | |
| 700 | 1 | |a Kucheryavyy, Y A |e verfasserin |4 aut | |
| 700 | 1 | |a Levchenko, A I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Terapevticheskii arkhiv |d 1949 |g 92(2020), 12 vom: 15. Dez., Seite 43-47 |w (DE-627)NLM000055425 |x 0040-3660 |7 nnns |
| 773 | 1 | 8 | |g volume:92 |g year:2020 |g number:12 |g day:15 |g month:12 |g pages:43-47 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.26442/00403660.2020.12.200430 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 92 |j 2020 |e 12 |b 15 |c 12 |h 43-47 | ||